ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106442 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106442; 2) Community: the network communities that were significantly associated with the response to NSC 106442; 3) Molecule: the relationships between components within communities and NSC 106442; 4) MDR: the compounds that were significantly associated with the NSC 106442.

NSC Compound Enrichment Correlation
NSC 18805 .gamma.-Thujaplicine 0.0105244982742821 0.2976817
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0105244982742821 0.42783698
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0105244982742821 0.48212351
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0105244982742821 -0.025984522
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0105244982742821 0.16364381
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0105244982742821 0.47177544
NSC 42972 Null 0.0105244982742821 0.49089572
NSC 603071 Aminocamptothecin 0.0105244982742821 0.035473525
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0105244982742821 0.11422655
NSC 606497 Camptothecin Derivative 0.0105244982742821 0.010699679
Total:108  Current:27    [First] [Prev] [Next] [Last]